HopeStage
Back to all studies
CompletedNCT00204061

Amisulpride with supportive care for late early-warning signs of psychosis

About this titleRead the official source — NCT00204061
Medication studyAges 14–36GermanySchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 14 years to 36 years.

Listed locations
CologneSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2001
Recruitment status
Completed
Enrollment listed in the registry
124
Sponsor
University of Cologne
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
From 14 Years to 36 Years
Official registry ID
NCT00204061
Official title
Show the full official title

Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cologne

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Cologne, a university.

Did this study involve medication?

Yes. The study involved medication, including Amisulpride.

Who was this study for?

Listed age limits: 14 years to 36 years.

Want to explore more studies?

Explore studies